fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Multivitamins

All products: not a benefit

Pregnancy Multivitamin · DIN 02535718 · · tablet

Off-Formulary Interchangeable, not an ODB benefitDormant since August 3, 2026 · checked October 5, 2026 · What does dormant mean?
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Pregnancy Multivitamin · DIN 02535718 Manufacturer: Jamp Pharma Corporation; listing date 2025-02-28 Health Canada: Dormant since 2026-08-03 · brand PREGNANCY MULTIVITAMIN · ATC B03AE04 IRON, MULTIVITAMINS AND MINERALS · form Tablet · route Oral · ingredients VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8 MG, VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10 MG, VITAMIN B12 (CYANOCOBALAMIN) 12 MCG, BETA-CAROTENE 1.6 MG, NICOTINAMIDE 20 MG, D-PANTOTHENIC ACID (CALCIUM PANTOTHENATE) 5 MG, CALCIUM (CALCIUM CARBONATE) 300 MG, IODINE (POTASSIUM IODIDE) 0.15 MG, VITAMIN B2 (RIBOFLAVIN) 3.4 MG, ASCORBIC ACID (ASCORBIC ACID) 120 MG, VITAMIN B1 (THIAMINE MONONITRATE) 3 MG, MAGNESIUM (MAGNESIUM OXIDE) 50 MG, IRON (FERROUS FUMARATE) 35 MG, ZINC (ZINC OXIDE) 15 MG, COPPER (COPPER GLUCONATE) 2 MG, FOLIC ACID 1.1 MG, VITAMIN D3 (CHOLECALCIFEROL) 600 UNIT · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02535718)

Source record
DIN 02535718: Pregnancy Multivitamin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 882800066; group id 889; item number 2136; lccId None; manufacturer id JPC Source form: Tab; strength: None Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $0.3125; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02535718 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102454
Interchangeable products
Pregvit · DIN 02451573 · not recorded
Shortage status: active shortage (reported December 2, 2024, estimated to end December 31, 2026, last updated September 15, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02535718
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since August 3, 2026 — choose a marketed DIN from the same-category list.

Pregnancy Multivitamin Folic 5 · DIN 02537478 · · tablet

Off-Formulary Interchangeable, not an ODB benefitDormant since August 3, 2026 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Pregnancy Multivitamin Folic 5 · DIN 02537478 Manufacturer: Jamp Pharma Corporation; listing date 2025-02-28 Health Canada: Dormant since 2026-08-03 · brand PREGNANCY MULTIVITAMIN FOLIC 5 · ATC B03AE04 IRON, MULTIVITAMINS AND MINERALS · form Tablet · route Oral · ingredients NICOTINAMIDE 20 MG, CALCIUM (CALCIUM CARBONATE) 300 MG, FOLIC ACID 5 MG, ASCORBIC ACID 120 MG, BETA-CAROTENE 1.6 MG, VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8 MG, COPPER (COPPER GLUCONATE) 2 MG, ZINC (ZINC OXIDE) 15 MG, VITAMIN D3 (CHOLECALCIFEROL) 600 UNIT, D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5 MG, VITAMIN B12 (CYANOCOBALAMIN) 12 MCG, MAGNESIUM (MAGNESIUM OXIDE) 50 MG, VITAMIN B1 (THIAMINE MONONITRATE) 3 MG, VITAMIN B2 (RIBOFLAVIN) 3.4 MG, IODINE (POTASSIUM IODIDE) 0.15 MG, IRON (FERROUS FUMARATE) 35 MG, VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02537478)

Source record
DIN 02537478: Pregnancy Multivitamin Folic 5 Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 882800067; group id 889; item number 2137; lccId None; manufacturer id JPC Source form: Tab; strength: None Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $0.5025; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02537478 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102618
Interchangeable products
Pregvit Folic 5 · DIN 02451581 · not recorded
Shortage status: active shortage (reported December 2, 2024, estimated to end December 31, 2026, last updated September 15, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02537478
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since August 3, 2026 — choose a marketed DIN from the same-category list.

Pregvit · DIN 02451573 · · tablet

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-07 — choose a marketed DIN from the same-category list.Discontinued March 7, 2025 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-07 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2025-03-07 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Pregvit · DIN 02451573 Manufacturer: Duchesnay Inc.; listing date 2025-02-28 Health Canada: Cancelled post market since 2025-03-07 · brand PREGVIT · ATC B03AE04 IRON, MULTIVITAMINS AND MINERALS · form Tablet · route Oral · ingredients ASCORBIC ACID (ASCORBIC ACID) 120 MG, VITAMIN D3 (CHOLECALCIFEROL) 600 UNIT, BETA-CAROTENE 1.6 MG, NICOTINAMIDE 20 MG, FOLIC ACID 1.1 MG, VITAMIN B1 (THIAMINE MONONITRATE) 3 MG, ZINC (ZINC OXIDE) 15 MG, VITAMIN B12 (CYANOCOBALAMIN) 12 MCG, MAGNESIUM (MAGNESIUM OXIDE) 50 MG, VITAMIN B2 (RIBOFLAVIN) 3.4 MG, VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10 MG, VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8 MG, COPPER (CUPRIC OXIDE) 2 MG, D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5 MG, IRON (FERROUS FUMARATE) 35 MG, CALCIUM (CALCIUM CARBONATE) 300 MG, IODINE (POTASSIUM IODIDE) 0.15 MG · company Duchesnay inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Pregvit: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02451573)

Source record
DIN 02451573: Pregvit Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 882800066; group id 889; item number 2136; lccId None; manufacturer id DUI Source form: Tab; strength: None Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02451573 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93788
Interchangeable products
Pregnancy Multivitamin · DIN 02535718 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02451573
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since March 7, 2025 — choose a marketed DIN from the same-category list.

Pregvit Folic 5 · DIN 02451581 · · tablet

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-31 — choose a marketed DIN from the same-category list.Discontinued March 31, 2025 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2025-03-31 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled post market since 2025-03-31 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Pregvit Folic 5 · DIN 02451581 Manufacturer: Duchesnay Inc.; listing date 2025-02-28 Health Canada: Cancelled post market since 2025-03-31 · brand PREGVIT FOLIC 5 · ATC B03AE04 IRON, MULTIVITAMINS AND MINERALS · form Tablet · route Oral · ingredients FOLIC ACID 5 MG, VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 13.8 MG, ASCORBIC ACID (ASCORBIC ACID) 120 MG, MAGNESIUM (MAGNESIUM OXIDE) 50 MG, VITAMIN D3 (CHOLECALCIFEROL) 600 UNIT, IRON (FERROUS FUMARATE) 35 MG, BETA-CAROTENE 1.6 MG, NICOTINAMIDE 20 MG, IODINE (POTASSIUM IODIDE) 0.15 MG, CALCIUM (CALCIUM CARBONATE) 300 MG, D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 5 MG, ZINC (ZINC OXIDE) 15 MG, VITAMIN B2 (RIBOFLAVIN) 3.4 MG, VITAMIN B12 (CYANOCOBALAMIN) 12 MCG, VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10 MG, COPPER (CUPRIC OXIDE) 2 MG, VITAMIN B1 (THIAMINE MONONITRATE) 3 MG · company Duchesnay inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Pregvit Folic 5: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02451581)

Source record
DIN 02451581: Pregvit Folic 5 Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 882800067; group id 889; item number 2137; lccId None; manufacturer id DUI Source form: Tab; strength: None Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02451581 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=93789
Interchangeable products
Pregnancy Multivitamin Folic 5 · DIN 02537478 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02451581
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since March 31, 2025 — choose a marketed DIN from the same-category list.

Multivitamins for infusion

All strengths: General benefit; same patient cost rules

Shared coverage and patient cost rules
StatusGeneral benefit
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.

Multi-12 · DIN 02100606 · · injection-2x5mL vial

General benefitMarketed · checked October 5, 2026
Write on scriptno code needed
No interchangeable product listed in the Ontario extract
Multi-12 · DIN 02100606 Manufacturer: Sandoz Canada Inc.; listing date 2019-04-30 Health Canada: Marketed since 2025-10-23 · brand MULTI 12 · ATC B05XC VITAMINS · form Solution · route Intravenous · ingredients VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE) 0.72 MG/ML, VITAMIN D 40 UNIT/ML, VITAMIN B12 (VITAMIN B12) 1 MCG/ML, VITAMIN B1 (THIAMINE HYDROCHLORIDE) 0.6 MG/ML, BIOTIN 12 MCG/ML, VITAMIN E 2 UNIT/ML, FOLIC ACID 80 MCG/ML, DEXPANTHENOL 3 MG/ML, ASCORBIC ACID 20 MG/ML, PYRIDOXINE HYDROCHLORIDE 0.8 MG/ML, NICOTINAMIDE 8 MG/ML, VITAMIN A 660 UNIT/ML · company Sandoz canada incorporated · schedule Ethical
Re-check Health Canada status and shortages (live) · Health Canada product record

Multi-12: Formulary list price $23.00 per unit (the source does not state the unit; exact figure $23.0000). What the ministry pays, not the patient.

Ministry pays: $23.0000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02100606)

Source record
DIN 02100606: Multi-12 Raw flags: sec3=Y Item: 882800041; group id 890; item number 2138; lccId None; manufacturer id SDZ Source form: Inj-2x5mL Vial Pk; strength: None Recorded listing: General benefit Source prices (unrounded): $23.0000; ministry $23.0000 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02100606 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=16462
Shortage status: active shortage (reported May 29, 2026, last updated June 4, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02100606
Shortage record checked October 6, 2026

Multi 12/K1 Pediatric · DIN 02242529 · · injection-4mL+1mL vial

General benefitMarketed · checked October 5, 2026
Write on scriptno code needed
No interchangeable product listed in the Ontario extract
Multi 12/K1 Pediatric · DIN 02242529 Manufacturer: Sandoz Canada Inc.; listing date 2019-04-30 Health Canada: Marketed since 2006-07-06 · brand MULTI-12/K1 PEDIATRIC · ATC B05XC VITAMINS · form Solution · route Intravenous · ingredients PYRIDOXINE HYDROCHLORIDE 1 MG/VIAL, VITAMIN D 400 UNIT/VIAL, VITAMIN K1 0.2 MG/VIAL, VITAMIN A 2300 UNIT/VIAL, ASCORBIC ACID (ASCORBIC ACID) 80 MG/VIAL, VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 7 UNIT/VIAL, VITAMIN B12 (CYANOCOBALAMIN) 1 MCG/VIAL, VITAMIN B1 (THIAMINE HYDROCHLORIDE) 1.2 MG/VIAL, VITAMIN B2 (RIBOFLAVIN-5-PHOSPHATE) 1.4 MG/VIAL, BIOTIN 20 MCG/VIAL, DEXPANTHENOL 5 MG/VIAL, NICOTINAMIDE 17 MG/VIAL, FOLIC ACID 140 MCG/VIAL · company Sandoz canada incorporated · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Multi 12/K1 Pediatric: Formulary list price $41.80 per unit (the source does not state the unit; exact figure $41.8000). What the ministry pays, not the patient.

Ministry pays: $41.8000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02242529)

Source record
DIN 02242529: Multi 12/K1 Pediatric Raw flags: sec3=Y Item: 882800056; group id 890; item number 2139; lccId None; manufacturer id SDZ Source form: Inj-4mL+1mL Vial Pk; strength: None Recorded listing: General benefit Source prices (unrounded): $41.8000; ministry $41.8000 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02242529 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66277
Shortage status: resolved shortage (ended February 5, 2024); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242529
Shortage record checked October 6, 2026
Other drugs in the same formulary class (88:28 Multivitamins) and how they are covered
No products matched this class search: “88:28”. This is a search result, not a decision about coverage. Try a different class name, abbreviation or class code. Search this as a medication name or DIN
Full class listing Related classes: 88:08 Vitamin B, 88:12 Vitamin C, 88:16 Vitamin D Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no marketed product found
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE Multi-12® is indicated for use as a supplement to parenteral nutrition for adults and children aged 11 and above. Its administration helps to maintain plasma vitamin levels and helps to prevent depletion of endogenous stores of the vitamins and development of subsequent deficiency symptoms. It is also indicated where there are increased requirements for vitamins due to stress situations such as surgery, extensive burns, fractures and other trauma, severe infectious diseases, and comatose states. Vitamin therapy should be initiated before development of clinical signs of vitamin deficiency. Patients with multiple vitamin deficiencies or with markedly increased requirements may be given multiples of the daily dosage for two or more days as indicated by the clinical status. https://pdf.hres.ca/dpd_pm/00082180.PDF PM date: OCT 23, 2025 Source product: MULTI 12; DIN 02100606; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Pregnancy Multivitamin · DIN 02535718 Shortage status: active shortage (reported 2024-12-02, estimated to end 2026-12-31, last updated 2026-09-15); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02535718

Check this DIN again

Pregnancy Multivitamin Folic 5 · DIN 02537478 Shortage status: active shortage (reported 2024-12-02, estimated to end 2026-12-31, last updated 2026-09-15); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02537478

Check this DIN again

Multi-12 · DIN 02100606 Shortage status: active shortage (reported 2026-05-29, last updated 2026-06-04); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02100606

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, September 10, 2026 ↗)

Other review policies

For Pregnancy Multivitamin, Pregnancy Multivitamin Folic 5, Pregvit, Pregvit Folic 5: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026